about
Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital.Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia.Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.Pneumonia complicating pandemic (H1N1) 2009: risk factors, clinical features, and outcomes.Prognosis of 2009 A(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy.Pandemic 2009 A(H1N1) infection requiring hospitalization of elderly Spanish adults.Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease.Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases.Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: data from the RESITRA/REIPI cohort.Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections.Intramedullary cervical spinal cord abscess by viridans group Streptococcus secondary to infective endocarditis and facilitated by previous local radiotherapy.Spontaneous epidural abscess: analysis of 15 cases with emphasis on diagnostic and prognostic factors.Aspergillus tracheobronchitis: report of 8 cases and review of the literature.Executive summary. Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical MicrManagement of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) anHow to assist clinicians in improving antimicrobial prescribing: tools and interventions provided by stewardship programs.Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain.High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.Fever, abdominal tenderness and peripheral eosinophilia in a frequent traveler.Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: an underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study.High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance.Fever in a kidney transplant recipient: no facts and many interactions.Coxiella burnetii infection of left atrial thrombus mimicking an atrial myxoma.Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.Fever due to inflammation in acute aortic dissection: Description and proposals for diagnostic and therapeutic management.Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3.[Fever and left lower limb edema in a 39-year-old man].Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study.Significance of the isolation of Staphylococcus aureus from a central venous catheter tip in the absence of concomitant bacteremia: a clinical approach.Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options.Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial.Detection of Epstein-Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications.Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly.Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation.
P50
Q30389171-370C1B89-C439-4B86-844E-F78E1C2AABAFQ30399360-C3ED7A61-3AE0-4627-9D34-23D72A3D3920Q30400874-4EB86861-0FDD-4573-8C9C-75B03969B5B2Q30406323-1B31CD6B-C170-4950-B06F-6581008790C0Q30412502-D67B012D-3263-409D-A0C3-9A466A43011CQ30414804-C33DA99F-FDBA-4816-B323-61A7A99BCDDBQ30422526-68D788FF-5E42-4192-89AB-A03FAB6C51B4Q33346990-3B160D88-96C1-4A09-8B40-02D59B29E5AFQ34003488-424C68F6-7BF0-434B-997A-285E92F62DBCQ34309608-5E40C10E-E345-4440-A0BE-E882C4A78C84Q37362048-40D8556E-C390-41E5-877A-356D990C9CA0Q37588169-8110814A-F3A0-4EED-A66B-D6C2E3AD4039Q38038987-83062214-16B3-405B-BC1E-7AB22599DCAFQ38092937-6BDC3072-2AFE-4F4B-83A2-80E466F0FA14Q38092938-EB94B4B4-7259-45EB-9565-FB96A921D7C1Q38152935-1EDCB934-1EFA-407D-A26D-CE49FD263539Q38822159-A4074105-54A8-4FCF-92A8-0DDD3603F621Q39262349-5AAF675B-1ECA-4A30-AB25-348D0A2B70CBQ39756833-7E81E7D9-8286-421E-B3B6-67FFC292389DQ40055908-D10DC612-2D1C-4DF0-B588-80EAF205260AQ40103658-ED4DE748-83EB-4F73-8233-7D07BD00698FQ40125692-2DA08722-F71A-44D8-A00C-F2D2F3FD4E6BQ40263706-47175B70-1FC8-4AB5-99F3-E14A7E3D9486Q40270352-2C9FC14D-437A-48C1-BB3E-5C1FBD6E6FC7Q40271648-243D2BC7-D328-4F49-B8BF-CC399D2678D2Q40293785-C5B111F3-2867-4F94-867A-7DF9A8C0D60DQ40346684-393F3FEF-813F-40EC-B905-5BF10EC754A0Q40358580-731FB4CD-1ED5-408B-B6C3-C281AEDCC0ECQ40359335-AB1D4BF8-AFE0-430B-BC93-EC33E99A84B3Q40472051-C76B0BF7-9FBB-4268-B963-F5671F9C4F6BQ40540881-89245636-F0BA-4E6A-A67E-C82A5F2199B3Q40544268-C0FA4504-544F-4DCB-8B8D-7F9849780A27Q40593554-D5718D4B-ECCF-42E5-B077-C01A6FA7626BQ40627024-87DC53F1-2D54-45D4-B223-3DDE048795ABQ40630330-53802FA1-047E-4A0D-B0D3-5A9339D8E7C1Q40645930-9ED4F64A-751D-4B3D-AE00-7538964EC261Q40710377-CFEC75CA-EC15-40C3-B197-69D3C1F6DA74Q40721769-4AB1C2D8-44DF-4431-BD3A-D3FB42BED457Q40848041-3C77E11D-F2FF-432D-82C1-E961DF8521FAQ42223053-189124D4-EF37-40DE-8316-1AA4BA72DDA8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francisco López-Medrano
@ast
Francisco López-Medrano
@en
Francisco López-Medrano
@es
Francisco López-Medrano
@nl
Francisco López-Medrano
@sl
type
label
Francisco López-Medrano
@ast
Francisco López-Medrano
@en
Francisco López-Medrano
@es
Francisco López-Medrano
@nl
Francisco López-Medrano
@sl
prefLabel
Francisco López-Medrano
@ast
Francisco López-Medrano
@en
Francisco López-Medrano
@es
Francisco López-Medrano
@nl
Francisco López-Medrano
@sl
P106
P21
P31
P496
0000-0001-5333-7529